Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

The global Embolic Protection Devices Market is valued at $601 million in 2023 and is projected to reach $1,250 million by ...

Abelacimab is currently in Phase 3 development, with the lead indication for prevention of stroke and systemic embolism in patients ... Three Phase 3 clinical trials are ongoing for patients at risk ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation.

The long-term risk for heart disease following a COVID infection was true for anyone, even for people who don't have any ...

According to the World Health Organization (WHO), one in four people is at risk of stroke during their lifetime. What's even worse is that certain factors can increase your susceptibility to life ...

This substantially increased chance is comparable to other well-established stroke risk factors like diabetes, researchers say. The observational study, which probed data on 13,205 people aged 65 ...

Heavy smoking was associated with a significantly increased risk for cryptogenic ischemic stroke within a large cohort of younger adults from across Europe, data show. “Smoking is a well-documented ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Aims Previous studies have suggested an association between retinal artery occlusion (RAO) and ischaemic stroke (IS), both ...